SS
Santosh Shrirangrao Jadhav
About Santosh Shrirangrao Jadhav
Data last updated:
Santosh Shrirangrao Jadhav is an Additional Director at Biopole Pharmaceutical Private Limited (since 2022). The companies operate in Pharma and Healthcare. Earlier, Santosh Shrirangrao Jadhav was a Director at Preeminence Life Care Private Limited (2023–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 28 May 2022 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 May 2023 | 2021 | Under Process Of Striking Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Santosh Shrirangrao Jadhav
| Name | DIN | Company | Designation |
|---|---|---|---|
| Tejas Raghunath Chougale | 09544893 | Biopole Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Santosh Shrirangrao Jadhav
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Santosh Shrirangrao Jadhav
Santosh Shrirangrao Jadhav currently holds 1 directorship: Biopole Pharmaceutical Private Limited (Additional Director, since 28 May 2022).
Santosh Shrirangrao Jadhav was first appointed on 28 May 2022 as Additional Director at Biopole Pharmaceutical Private Limited. The most recent appointment on record is 08 May 2023 at Preeminence Life Care Private Limited.
Santosh Shrirangrao Jadhav held 1 earlier board appointment: Preeminence Life Care Private Limited (Director, 08 May 2023 to 01 Feb 2025).
The current boards of Santosh Shrirangrao Jadhav's companies include Tejas Raghunath Chougale (Biopole Pharmaceutical Private Limited).